ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Quality Indicators"

  • Abstract Number: 1069 • ACR Convergence 2024

    Improving Triage Accuracy of Unclear Rheumatology Referrals: A Quality Improvement Study

    Stephanie Gottheil1, Chiara Gottheil2 and Joseph Carson3, and Canadian Rheumatology Association - CIORA Grant, 1London Rheumatology, London, 2London Rheumatology, London, Canada, 3London Rheumatology, London, ON, Canada

    Background/Purpose: Patients with early inflammatory arthritis (EIA) need to be seen urgently to initiate treatment. Our community rheumatology clinic in Ontario, Canada was concerned that…
  • Abstract Number: 1078 • ACR Convergence 2024

    Improving SLEDAI-2K Documentation for Childhood-Onset Systemic Lupus Erythematosus (cSLE) in a Pediatric Rheumatology Clinic Using Quality Improvement Methodology

    Ivana Stojkic1, Vinchelle Hardison1, Fatima Barbar-Smiley2, Mahmoud Kallash3, Hiren Patel3, Jonnie Lee Hughes3, James Gallop3, Ashlee Leone3, Emily Duff3, Alysha Taxter1, Stacy Ardoin1 and Vidya Sivaraman4, 1Nationwide Children's Hospital, Columbus, OH, 2Amgen, Columbus, OH, 3Nationwide Children's Hosptial, Columbus, OH, 4Nationwide Children's Hospital/ The Ohio State University, Columbus, OH

    Background/Purpose: Management of Systemic lupus erythematosus (SLE) requires accurate, timely disease activity monitoring for optimal treatment and research. The SLEDAI-2K provides objective clinical and laboratory…
  • Abstract Number: 1292 • ACR Convergence 2024

    Primary Care Provider Educational Tool to Improve Osteoarthritis Management in the Primary Care Setting

    Tessalyn Morrison1, Luke Giangregorio2, Emily Hadley-Strout1 and Jeanne Gosselin3, 1University of Vermont Medical Center, Burlington, VT, 2Larner College of Medicine at the University of Vermont, Burlington, VT, 3University of Vermont Medical Center, Waterbury, VT

    Background/Purpose: Osteoarthritis is the most common form of arthritis and its prevalence is increasing. As a non-inflammatory type of arthritis, it can be managed in…
  • Abstract Number: 1315 • ACR Convergence 2024

    From Presentation to Publication: Tracking the Publication Rate of Abstracts Presented at American College of Rheumatology Convergence Conference in the Years 2015 and 2018

    Shreena Kamlesh Gandhi1, Shivani Patel2, Saransh Narang3, Aayushi Rajani3 and Kaleb Michaud4, 1KU School of Medicine, Wichita, Wichita, KS, 2Washington University in St. Louis, St. Louis, MO, 3Medical College, Baroda, Baroda, India, 4University of Nebraska Medical Center, Omaha, NE

    Background/Purpose: The ACR Convergence meeting attracts rheumatology researchers worldwide to present their peer- reviewed abstracts for a global audience either as a poster or oral…
  • Abstract Number: 1547 • ACR Convergence 2024

    Hydroxychloroquine and Prednisone Use by Individuals Diagnosed with Systemic Lupus Erythematosus in the TriNetX Research Database

    Moises Narvaez1, Mujeeb Basit2 and David Karp3, 1UT Southwestern Medicial Center, Dallas, 2UT Southwestern Medical Center, Dallas, 3UT Southwestern Medical Center, Dallas, TX

    Background/Purpose: The current treatment guidelines for systemic lupus erythematosus emphasize the universal use of antimalarials such as hydroxychloroquine (HCQ) unless contraindicated as well as limited…
  • Abstract Number: 1940 • ACR Convergence 2024

    Timely Initiation of Steroid Sparing Therapy in Uveitis Patients – a Quality Improvement Initiative

    Bibi Ayesha1, Claudia Castiblanco2, Clement Tagoe3, Sarah Baron2 and Sharon Rikin2, 1Montefiore Medical Center, Metuchen, NJ, 2Montefiore Medical Center, Bronx, NY, 3Montefiore Medical Center, New York

    Background/Purpose:  Uveitis is the inflammation of the eye, which is third leading cause of preventable blindness in the United States. Corticosteroids are the first line…
  • Abstract Number: 2164 • ACR Convergence 2024

    Boosting Adherence to “Sick Day Rules”: A Quality Improvement Study in Rheumatology Outpatients on Immunosuppressive Medications, Results of Post-intervention Phase

    Merve Aksoy*, Pamela Gonzalez Manrique, Heinrich-Karl Greenblatt and Katarzyna Gilek-Seibert, Roger Williams Medical Center, Providence, RI

    Background/Purpose: Acute infections are common among rheumatology outpatients receiving immunosuppressive medications (IS). Expert guidance advises pausing IS during acute infection, resuming only when clinically improved,…
  • Abstract Number: 2179 • ACR Convergence 2024

    Evaluation of Diagnostic Concordance Between Telehealth Encounters and In-Person Follow-up Assessments in Pediatric Rheumatology

    Laura Aisenberg1, Irit Rasooly1, Pamela Weiss2, Jon Burnham3 and Anna Costello1, 1Children's Hospital of Philadelphia, Philadelphia, PA, 2Children's Hospital of Philadelphia, Philadelphia, PA, 3Children's Hospital of Philadelphia, Bryn Mawr, PA

    Background/Purpose: In early 2020, much of the country’s pediatric rheumatology practice shifted to a telehealth model secondary to the SARS-CoV-2 pandemic. During this discrete period,…
  • Abstract Number: 2622 • ACR Convergence 2024

    Quality of Care for Childhood-Onset Lupus Nephritis: Suboptimal Completion of Disease Activity Monitoring

    Emily Smitherman1, Justin Leach1, Aimee Hersh2, Melissa Mannion1, Jinoos Yazdany3 and Jeffrey Curtis4, 1University of Alabama at Birmingham, Birmingham, AL, 2University of Utah, Salt Lake City, UT, 3UCSF, San Francisco, CA, 4University of Alabama at Birmingham, Hoover, AL

    Background/Purpose: Poorly controlled childhood-onset lupus nephritis (cLN) can lead to end-stage kidney disease (ESKD), requiring kidney replacement therapies with substantial financial and quality of life…
  • Abstract Number: 0140 • ACR Convergence 2024

    Estimation of 10-year Cardiovascular (CV) Risk and Traditional CV Risk Factors Distribution in Patients with Rheumatoid Arthritis from Three Italian Macro-areas

    Fabiola Atzeni1, Fabio Cacciapaglia2, Elena Bartoloni Bocci3, Matteo Piga4, Garifallia Sakellariou5, Ombretta Viapiana6, Alessandro Giollo7, SIMONE PARISI8, Maria Sole Chimenti9, Ennio Giulio Favalli10, Addolorata Corrado11, Eleonora Celletti12, Ivan Giovannini13, Serena Guiducci14, Elisa Gremese15, Andreina Manfredi16, Francesca Romana Spinelli17 and Gian Luca Erre18, and "Cardiovascular Obesity and Rheumatic DISeaases" Study Group of the Italian Society of Rheumatology, 1University of Messina, Italy, Messina, Italy, 2Rheumatology Unit DiMePRe-J, University and AOU Policlinico of Bari, Italy, Bari, Italy, 3Rheumatology Unit. Department of Medicine, Perugia, Perugia, Italy, 4Rheumatology Unit - Department of Medical Sciences and Public Health, University of Cagliari, Monserrato, Italy, 5Department of Internal Medicine and Medical Therapy, University of Pavia, and Istituti Clinici Scientifici Maugeri IRCCS Pavia,, Pavia, Italy, 6Rheumatology Unit, University of Verona, Verona, Italy, 7Azienda Ospedale Università Padova, Padova, Padua, Italy, 8Rheumatology Unit, Azienda Ospedaliero Universitaria Città della Salute e della Scienza di Torino, TURIN, Italy, 9Rheumatology, Allergology and Clinical Immunology, University of Rome Tor Vergata, Roma, Italy, 10ASST Gaetano Pini-CTO, Milan, Lombardia, Italy, 11Rheumatology Unit, University of Foggia, Foggia, Italy, 12Medical Clinic, SS. Annunziata Hospital of Chieti, Department of Medicine and Science of Aging, G. D'Annunzio University of Chieti-Pescara, Chieti, Italy, 13Azienda Sanitaria Universitaria Friuli Centrale, Udine, Udine, Italy, 14University of Florence, Pistoia, Italy, 15Catholic University of the Sacred Heart, Rome, Rome, Italy, 16University of Modena and Reggio Emilia, Modena, 17Sapienza University of Rome, Rome - Italy, Roma, Rome, Italy, 18Rheumatology Unit - University of Sassari, Sassari, Italy

    Background/Purpose: Geographic origins can significantly impact people’s health, particularly in Italy, where regional health disparities are among the most pronounced [1]. Rheumatoid arthritis (RA) is…
  • Abstract Number: 0199 • ACR Convergence 2024

    Delivery of Guideline Concordant Care in Childhood-Onset Lupus Nephritis

    Alisha Akinsete1, Mangala Rajan2, Orysya Soroka2, Karen Onel3, Monika Safford2 and Iris Navarro Millan4, 1Weill Cornell Medicine/ Hospital for Special Surgery, New York, NY, 2Weill Cornell Medicine, New York, NY, 3HSS, New York, NY, 4Weill Cornell Medicine, Hospital for Special Surgery, New York, NY

    Background/Purpose: 50-80% of children with childhood-onset systemic lupus erythematosus (cSLE) develop lupus nephritis (LN). Children from historically marginalized communities are disproportionately affected by cSLE and…
  • Abstract Number: 0255 • ACR Convergence 2024

    “Rheum” to Improve: Have Patients Attending the Young Adult Systemic Erythematosus (YASLE) Clinic Received All Appropriate Vaccinations? A Quality Improvement Initiative

    Razan Al Yaarubi1, Amanda Steiman1 and Earl Silverman2, 1University of Toronto, Toronto, ON, Canada, 2Silverman, Toronto, ON, Canada

    Background/Purpose: Infections are a leading cause of morbidity and mortality in patients with childhood-onset systemic lupus erythematosus (cSLE). Vaccination is a powerful tool to prevent…
  • Abstract Number: 0418 • ACR Convergence 2024

    Improving Documentation of Contraception and Pregnancy Intention in Rheumatology Practice

    Megan Clowse1, Puneet Bajaj2, Bonnie Bermas2, Julie Chiesa3, Kathryn Dao4, Pamela Freeman5, Bansari Gujar6, Brittany Hill7, Kelley Jones8, Richard Jones9, Ann Marslett10, Brooke Mills11, James Roberts2, Amanda Snyderman8 and Leah Zulig12, 1Duke University, Chapel Hill, NC, 2UT Southwestern Medical Center, Dallas, TX, 3InfoDirectors, Durham, NC, 4Rheum101, Rockville, MD, 5Rheumatology Associates of Central Florida, Orlando, FL, 6Rheumatology Associates of Baltimore, Towson, MD, 7Clinic for Rheumatic Disease, Tuscaloosa, AL, 8Duke University School of Medicine, Durham, 9Clinic for Rheumatic Diseases, Northport, AL, 10Rheumatology Associates of Baltimore, Baltimore, MD, 11UT Southwestern Medical Center, Fort Worth, TX, 12Duke University School of Medicine, Durham, NC

    Background/Purpose: Prior studies of RISE Registry found 9-11% of women of reproductive age with contraception documentation.  We sought to identify and assess methods to increase contraception documentation…
  • Abstract Number: 1067 • ACR Convergence 2024

    Initiation of Urate-Lowering Therapy in Patients Hospitalized with Gout Flare at a Single Center: Opportunity for Quality Improvement

    Ali Nasir1 and Nasir Khan2, 1Trinity Health Grand Rapids/Michigan State University, Grand Rapids, MI, 2Trinity Health Grand Rapids, Grand Rapids, MI

    Background/Purpose: Hospitalizations for gout flare have been increasing, doubling between 1993 to 2011 from 4.4 to 8.8 admissions per 100000 adults. Despite this increase, urate-lowering therapy (ULT)…
  • Abstract Number: 0482 • ACR Convergence 2023

    Preference and Relative Sensitivity of Indicators Reporting Response Rate in Pharmaceutical Trials of Psoriasis and Psoriatic Arthritis

    Jingru Tian1, Shuntong Kang2, Dingyao Zhang3 and Qianjin Lu4, 1Institute of Dermatology, Chinese Academy of Medical Sciences and Peking Union Medical College, Nanjing, China, 2Department of Dermatology, Hunan Key Laboratory of Medical Epigenomics, The Second Xiangya Hospital, Central South University, Nanjing, China, 3Graduate Program in Biological and Biomedical Sciences, Yale University, New Haven, CT, 4Hospital for Skin Diseases, Institute of Dermatology, Chinese Academy of Medical Sciences and Peking Union Medical College, Changsha, China

    Background/Purpose: Numerous indicators have been proposed to evaluate the efficacy for randomized clinical trials (RCTs) of psoriasis (Pso) and psoriatic arthritis (PsA), but the comparability…
  • 1
  • 2
  • 3
  • …
  • 6
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology